4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term SM) communities study

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

          Opioid overdose survivors have an increased risk for death. Whether use of medications for opioid use disorder (MOUD) after overdose is associated with mortality is not known.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

              Extended-release naltrexone (XR-NTX), an opioid antagonist, and sublingual buprenorphine-naloxone (BUP-NX), a partial opioid agonist, are pharmacologically and conceptually distinct interventions to prevent opioid relapse. We aimed to estimate the difference in opioid relapse-free survival between XR-NTX and BUP-NX.
                Bookmark

                Author and article information

                Contributors
                Journal
                Drug and Alcohol Dependence
                Drug and Alcohol Dependence
                Elsevier BV
                03768716
                April 2023
                April 2023
                : 245
                : 109804
                Article
                10.1016/j.drugalcdep.2023.109804
                36780768
                ce8ec69e-ace5-4ee4-89a8-15293f675f8e
                © 2023

                https://www.elsevier.com/tdm/userlicense/1.0/

                http://www.elsevier.com/open-access/userlicense/1.0/

                History

                Comments

                Comment on this article